Inventaire - your friends and communities are your best library

Fatty liver and FGF21 physiology

author

Eleftheria Maratos-Flier

1951 -

published in: Experimental Cell Research

date of publication: 2017-05-23

language: English

Cites articles 46

Date

Title

Authors

2017-01-01

Pathology of non-alcoholic fatty liver disease

Pierre Bedossa
2017-01-12

What have human experimental overfeeding studies taught us about adipose tissue expansion and susceptibility to obesity and metabolic complications?

Daniel J. Cuthbertson, John Wilding, Mark Hamer
2017-01-26

Loss of Hepatic CEACAM1: A Unifying Mechanism Linking Insulin Resistance to Obesity and Non-Alcoholic Fatty Liver Disease
2016-02-18

Nonalcoholic Fatty Liver Disease: Lipids and Insulin Resistance
2016-01-04

The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux

Gerald I. Shulman, Varman T Samuel
2016-02-08

Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease

C. Ronald Kahn
2016-09-26

ChREBP regulates fructose-induced glucose production independently of insulin signaling

Ludivine Doridot, Mark A. Herman, Jason K Kim
2016

Fibroblast Growth Factor 21 (FGF21) Protects against High Fat Diet Induced Inflammation and Islet Hyperplasia in Pancreas

Eleftheria Maratos-Flier, Jeffrey Scott Flier
2016-11-16

Circulating FGF21 in humans is potently induced by short term overfeeding of carbohydrates

Andreas Mæchel Fritzen, Erik A Richter, Anne-Marie Lundsgaard, Lise Madsen, Lene Secher Myrmel, Kim A Sjøberg, Jørgen Wojtaszewski, Bente Kiens
2016-11-23

A critical role for ChREBP-mediated FGF21 secretion in hepatic fructose metabolism

Ludivine Doridot, Mark A. Herman
2016-09-13

Nutrition Interventions for Chronic Liver Diseases and Nonalcoholic Fatty Liver Disease
2015-11-19

Understanding the Physiology of FGF21.

Eleftheria Maratos-Flier
2015-02-28

Role of fibroblast growth factor 21 in the early stage of NASH induced by methionine- and choline-deficient diet

Andrew Patterson
2014-07-09

Circulating FGF21 is liver derived and enhances glucose uptake during refeeding and overfeeding

Kathleen R Markan, David Mangelsdorf, Moosa Mohammadi, Matthew J Potthoff
2014-07-30

Fibroblast growth factor 21 limits lipotoxicity by promoting hepatic fatty acid activation in mice on methionine and choline-deficient diets

Eleftheria Maratos-Flier, Jeffrey Scott Flier, Alexei Kharitonenkov, Detlef Schuppan
2014-09-01

FGF21 is an endocrine signal of protein restriction

Thomas Laeger, Christopher D Morrison, Heike Münzberg, Leanne Redman
2014-10-08

Fructose ingestion acutely stimulates circulating FGF21 levels in humans

Eleftheria Maratos-Flier
2013-02-04

Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis

Claude B. Sirlin, An Tang, Gavin Hamilton, Jeffrey B. Schwimmer, Elizabeth M. Brunt, Joel E Lavine, Michael S Middleton, Mark Bydder, Tanya J Wolfson
2013-11-23

Fibroblast growth factor-21 is expressed in neonatal and pheochromocytoma-induced adult human brown adipose tissue

Marta Giralt, Francesc Villarroya, José M Gallego-Escuredo, Rubén Cereijo, Saverio Cinti
2013-06-20

Fibroblast growth factor 21: a novel biomarker for human muscle-manifesting mitochondrial disorders.
2013-07-08

Methionine and choline regulate the metabolic phenotype of a ketogenic diet

Eleftheria Maratos-Flier
2012-11-01

Nonalcoholic fatty liver disease in lean individuals in the United States.
2012-05-01

The problem of establishing relationships between hepatic steatosis and hepatic insulin resistance

Rudolf Zechner, Christopher B Newgard
2012-02-01

FGF21 regulates PGC-1α and browning of white adipose tissues in adaptive thermogenesis

Bruce Spiegelman, Eleftheria Maratos-Flier, Jeffrey Scott Flier, Alexei Kharitonenkov
2011-12-01

Nonalcoholic steatohepatitis: the therapeutic challenge of a global epidemic

Detlef Schuppan
2011-12-01

Early onset of fatty liver in growth-restricted rat fetuses and newborns
2011-03-10

Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits

Gudny Eiriksdottir, Ruben Hernaez, Joseph M Massaro, Albert V. Smith, Braxton D. Mitchell, Alan R. Shuldiner, Vilmundur Gudnason, Veikko Salomaa, Tamara B. Harris, Lenore J Launer, Udo Hoffmann, David S Siscovick, Benjamin F. Voight, Ingrid B Borecki, Mary Feitosa, Eric E Schadt, Christopher J O'Donnell, Laura M Yerges-Armstrong, Caroline S Fox, Rafn Benediktsson, Reedik Mägi, Joel N Hirschhorn, Elizabeth K Speliotes, Melissa N Garcia, Michael Marmot, Stephen Schwartz, John Jeffrey Carr, W. H. Linda Kao, Lauren Kim Roche, GIANT Consortium, GOLD Consortium, Johannah L Butler, Dushyant V Sahani
2011-06-01

Human fatty liver disease: old questions and new insights

Helen Hobbs, Jay D Horton, Jonathan C. Cohen
2011-02-25

Brown adipose tissue responds to cold and adrenergic stimulation by induction of FGF21.
2010-05-05

Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease

Eleftheria Maratos-Flier
2010-08-19

Increased serum FGF21 levels in patients with nonalcoholic fatty liver disease

Yusuf Yılmaz
2010-11

Obesity is a fibroblast growth factor 21 (FGF21)-resistant state

Eleftheria Maratos-Flier, Jeffrey Scott Flier, Alexei Kharitonenkov

Article - wd:Q38678326

Welcome to Inventaire

the library of your friends and communities

learn more